FDA Gives Nod to Aflibercept for Colon Cancer

(MedPage Today) — The FDA has approved the angiogenesis inhibitor aflibercept (Zaltrap) for patients with previously treated metastatic colorectal cancer.

Post a Comment

Comments are closed.